Maria Cristina Baschieri
University of Modena and Reggio Emilia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Maria Cristina Baschieri.
Journal of Materials Science: Materials in Medicine | 2011
Andrea Ardizzoni; Rachele Neglia; Maria Cristina Baschieri; Claudio Cermelli; Manuela Caratozzolo; Elena Righi; Beniamino Palmieri; Elisabetta Blasi
Hyaluronic acid (HA) has several clinical applications (aesthetic surgery, dermatology, orthopaedics and ophtalmology). Following recent evidence, suggesting antimicrobial and antiviral properties for HA, we investigated its effects on 15 ATCC strains, representative of clinically relevant bacterial and fungal species. The in vitro system employed allowed to assess optical density of broth cultures as a measure of microbial load in a time-dependent manner. The results showed that different microbial species and, sometimes, different strains belonging to the same species, are differently affected by HA. In particular, staphylococci, enterococci, Streptococcus mutans, two Escherichia coli strains, Pseudomonas aeruginosa, Candida glabrata and C. parapsilosis displayed a HA dose-dependent growth inhibition; no HA effects were detected in E. coli ATCC 13768 and C. albicans; S. sanguinis was favoured by the highest HA dose. Therefore, the influence of HA on bacteria and fungi warrants further studies aimed at better establishing its relevance in clinical applications.
International Journal of Immunopathology and Pharmacology | 2012
La Sala Gb; Andrea Ardizzoni; Francesco Capodanno; Lidia Manca; Maria Cristina Baschieri; Emanuele Soncini; Samuele Peppoloni; Elisabetta Blasi
Novel technologies that allow simultaneous assessment of multiple biomarkers provide new and promising diagnostic/prognostic approaches. By protein microarrays, here we analyzed amniotic fluids (AF) from 50 women with preterm delivery (PTD) and 50 control women, who delivered at term. In detail, cytokines, chemokines, matrix metalloproteinases and antigen-specific antibodies were assessed. The AF analysis showed significant differences between women with preterm and term delivery in the levels of IL-1α, IL-1β, IL-4, IL-6, IL-8, MCP-1, IFN-γ and anti-HSV2 IgG. No significant differences were observed in the levels of TNF-α, MMP-2, MMP-9 and specific IgG for seven vertically transmitted pathogens. In conclusion, we demonstrated the feasibility of protein microarrays in the diagnosis of early intrauterine inflammation. The significant association between the increased levels of certain cytokines and preterm delivery argues on their relevance as early pathogenetic markers for identification of risk patients.
International Journal of Immunopathology and Pharmacology | 2014
Andrea Ardizzoni; Brunella Posteraro; Maria Cristina Baschieri; Francesca Bugli; A. Sáez-Rosòn; Lidia Manca; Margherita Cacaci; F. Paroni Sterbini; C de Waure; M.J. Sevilla; Samuele Peppoloni; Maurizio Sanguinetti; Maria Dolores Moragues; Elisabetta Blasi
The increased incidence of invasive candidiasis and of patients at risk requires early diagnosis and treatment to improve prognosis and survival. The aim of this study was to set up a ten-protein array-based immunoassay to assess the IgG antibody responses against ten well-known immunogenic C. albicans proteins (Bgl2, Eno1, Pgk1, Pdc11, Fba1, Adh1, Als3, Hwp1, Hsp90 and Grp2) in 51 patients with invasive candidiasis (IC) and in 38 culture-negative controls (non-IC). Antibody levels were higher against Bgl2, Eno1, Pgk1, Als3, Hwp1 and Grp2, than against Adh1, Pdc11, Fba1 and Hsp90, irrespectively of the patient group considered. Moreover, the IgG levels against Bgl2, Eno1, Pgk1 and Grp2 were significantly higher in IC than in non-IC patients. Furthermore, the ROC curves generated by the analysis of the antibody responses against Bgl2, Grp2 and Pgk1 displayed AUC values above 0.7, thus discriminating IC and non-IC patients. According to these results, the employment of the microarray immunoassay (a rapid, sensitive and multiparametric system), in parallel with conventional diagnostics, can help to spot IC patients. This ultimately will allow to initiate an early, focused and optimized antifungal therapy.
Journal of Reproductive Immunology | 2011
Andrea Ardizzoni; Lidia Manca; Francesco Capodanno; Maria Cristina Baschieri; Ilaria Rondini; Samuele Peppoloni; Elena Righi; Giovanni Battista La Sala; Elisabetta Blasi
A protein microarray serological assay was used to assess the antibody profile of 102 women subjected to in vitro fertilization treatment. The studies were conducted on pairs of serum and follicular fluid samples, collected from each woman on the same day at the time of oocyte recovery. The samples, stored as frozen aliquotes, were assessed by both microarray and ELISA. Follicular fluids and sera were screened to detect the presence of specific IgG and IgM antibodies against seven vertically transmitted pathogens. The IgG reactivity of follicular fluids closely mirrored that of serum in all the patients and for all the antigens, with an agreement of more than 85%. IgM antibodies were undetectable in follicular fluids. The antibody patterns were subsequently related to the biological and clinical outcomes of in vitro fertilization cycles. The results showed that varicella zoster virus (VZV) IgG positive women and cytomegalovirus (CMV) IgG negative women had on average a higher number of inseminated, good quality oocytes compared to VZV IgG negative and CMV IgG positive women. In addition, the rate of successful embryo transfers was significantly higher in Toxoplasma gondii IgG negative women than in their positive counterparts. Overall, the microarray was proven to be a suitable tool for detecting analytes in follicular fluids, therefore supporting its application in a wide spectrum of investigations.
European Journal of Clinical Microbiology & Infectious Diseases | 2009
Andrea Ardizzoni; B. Capuccini; Maria Cristina Baschieri; Carlotta Francesca Orsi; Fabio Rumpianesi; Samuele Peppoloni; Claudio Cermelli; Marisa Meacci; A. Crisanti; P. Steensgaard; Elisabetta Blasi
New Microbiologica | 2011
Andrea Ardizzoni; Maria Cristina Baschieri; Lidia Manca; Carlotta Francesca Orsi; Claudia Venturelli; Marisa Meacci; Samuele Peppoloni; Claudio Farina; Elisabetta Blasi
Odontology | 2014
Andrea Ardizzoni; Luigi Generali; Elena Righi; Maria Cristina Baschieri; Francesco Cavani; Lidia Manca; Eleonora Lugli; Luigi Migliarese; Elisabetta Blasi; Rachele Neglia
Archive | 2013
Andrea Ardizzoni; Maria Cristina Baschieri; Lidia Manca; Marisa Meacci; Claudia Venturelli; Claudio Farina; Elisabetta Blasi
Archive | 2013
Andrea Ardizzoni; Maria Cristina Baschieri; Lidia Manca; Caterina Salvadori; Ginevra Marinacci; Claudio Farina; Pierluigi Viale; Elisabetta Blasi
Mycoses | 2013
A Sáez Rosón; Andrea Ardizzoni; Maria Cristina Baschieri; Francesca Bugli; F. Paroni Sterbini; Carlotta Francesca Orsi; Lidia Manca; Maurizio Sanguinetti; Brunella Posteraro; Cuétara; I Olazabal; García Ruiz Jc; Samuele Peppoloni; Elisabetta Blasi; Moragues